pec-01 cells
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2017 (NCT03162926)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- PancreasTissue restoration
Pancreas tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pec-01 cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04678557 | Phase 1/Phase 2 (Phase 2) | Jun 25, 2019 | ViaCyte |
| NCT03162926 | Phase 1 | Jun 1, 2017 | ViaCyte |
| NCT03163511 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2017 | ViaCyte |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ViaCyte | For profit | 3 | 3 | 2 | 2017 |
1 organizations
Page 1 / 1